Characteristics and Medication Use Patterns of Pregnancies With <scp>COVID</scp>‐19 Ending in Live‐Birth in the Sentinel System
In this retrospective evaluation, selected medication utilization was higher post-COVID-19 among pregnancies with COVID-19, compared to those without COVID-19 and to non-pregnancy episodes with COVID-19. However, the low use of COVID-19-specific medications underscores the need for a safety evaluation of therapies used for COVID-19 management in the pregnant population.
Authors
- Jolene Mosley
- Emma Hoffman
- Yueqin Zhao
- Elizabeth Messenger‐Jones
- Wei Hua (ORCID: https://orcid.org/0000-0002-2258-1892)
- David V. Cole
- Maria E. Kempner
- Jennifer G. Lyons (ORCID: https://orcid.org/0000-0002-5224-0298)
- Sengwee Toh (ORCID: https://orcid.org/0000-0002-5160-0810)
- José J. Hernández‐Muñoz (ORCID: https://orcid.org/0000-0002-2553-3159)
- Austin Cosgrove
- Leyla Şahin (ORCID: https://orcid.org/0000-0002-7685-7524)
- Danijela Stojanović (ORCID: https://orcid.org/0000-0001-7814-7625)
- Mayura Shinde
- Benedict H. W. Wong
- Susan E. Andrade (ORCID: https://orcid.org/0000-0002-9238-793X)
Institutions
- United States Food and Drug Administration (US)
- Center for Drug Evaluation and Research (US)
- Harvard University (US)
- University of Massachusetts Chan Medical School (US)
- Harvard Pilgrim Health Care (US)
- Reliant Medical Group (US)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1002/pds.70121
- Citations
- 2
- Primary Topic
- COVID-19 Impact on Reproduction
- Type
- article
- Field-Weighted Citation Impact
- 4.11
Funders
- Food and Drug Administration